Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients Caregivers Providers
Log In Ask a Question
PubMed This is a summary of 19 peer-reviewed journal articles Updated
Rheumatology

Can You Stop Colchicine Treatment for FMF?

At a Glance

For almost all patients with Familial Mediterranean Fever (FMF), colchicine is a lifelong medication that should never be stopped. Even if you have not had an attack in years, stopping colchicine allows silent inflammation to build up, which can cause permanent kidney damage and organ failure.

For the vast majority of people with Familial Mediterranean Fever (FMF), the answer is no — you should not stop taking colchicine, even if you have not had an attack in years. Colchicine is considered a lifelong preventive therapy, not a medication you only take when you feel sick [1][2]. While it is incredibly encouraging that you are completely symptom-free, stopping your medication carries severe, “invisible” risks that can cause permanent damage to your body [2].

The Danger of “Silent” Inflammation

When you go years without a fever or pain, it is natural to assume your FMF is gone or “cured.” However, FMF is a genetic condition, meaning the underlying cause is always present. In many patients, the immune system continues to simmer with low-level activity even when they feel perfectly healthy [3][4].

In medicine, this is called subclinical inflammation — inflammation that is happening inside your body without causing any outward symptoms or “clinical” signs like fevers or joint pain [3]. Colchicine works around the clock to suppress this silent inflammation [1]. If you stop taking it, the inflammation can quietly build back up, even if the painful attacks do not immediately return [3][5].

The Risk of AA Amyloidosis and Organ Damage

Why does silent inflammation matter if you feel fine? The biggest risk of untreated or undertreated FMF is a complication called AA amyloidosis [1][6].

When your body is constantly inflamed, it produces high amounts of an inflammatory protein called Serum Amyloid A (SAA). Over time, these proteins can clump together and form deposits (amyloid) in your vital organs, most commonly the kidneys [7][8]. This protein buildup physically damages the kidneys and can eventually lead to kidney failure [7]. Colchicine is the absolute best defense against AA amyloidosis, and its continuous use is required to protect your organs long-term [1][9]. Beyond the kidneys, lifelong colchicine also protects your heart and blood vessels from the damage caused by chronic inflammation [10][11].

How Doctors Measure Silent Inflammation

You and your doctor cannot rely on how you feel to know if your FMF is truly controlled. Instead, your doctor should regularly check specific blood tests:

  • SAA (Serum Amyloid A): The most sensitive marker for detecting hidden FMF inflammation between attacks [12][4].
  • CRP (C-Reactive Protein): Another common marker of general inflammation in the body [12][13].

The goal of FMF treatment is to keep these inflammatory markers at normal levels, not just to stop the painful attacks [14][11].

Coping with Side Effects

Sometimes the urge to stop medication isn’t because you feel cured, but because you are frustrated by gastrointestinal side effects like stomach upset. If this is the case, do not simply stop the medication on your own. Talk to your doctor immediately. They can often manage these issues by adjusting your dose, splitting the dose throughout the day, or exploring alternative medications (like IL-1 inhibitors) if you are truly resistant or intolerant to colchicine [14].

Are There Any Exceptions?

Medical literature shows that a highly select, very small group of adults (only about 3% of FMF patients) might be able to achieve a “colchicine-free remission” [15]. However, this is only considered for patients who have mild disease, zero signs of hidden inflammation on blood tests, and do not carry high-risk genetic mutations like M694V [16][17]. If you don’t know your specific genetic mutation, ask your doctor if genetic testing is appropriate for you [18].

Even for these rare individuals, stopping medication requires intense, ongoing monitoring by an FMF specialist because the risk of relapse and hidden organ damage remains high [16][5].

Never stop or reduce your colchicine dose without strict guidance and monitoring from your rheumatologist. Staying compliant with your daily medication is the single most important thing you can do to protect your long-term health [2][19].

Common questions in this guide

Can I stop taking colchicine if I haven't had an FMF attack in years?
No. Colchicine is considered a lifelong preventive medication for Familial Mediterranean Fever. Even if you feel completely healthy, your body may still have subclinical or 'silent' inflammation that can cause permanent organ damage if left untreated.
What are the risks of stopping colchicine for FMF?
Stopping your medication allows hidden inflammation to build up in your body, even if painful attacks do not return immediately. Over time, this chronic inflammation can lead to a serious complication called AA amyloidosis, which causes kidney damage and potential organ failure.
How does my doctor know if my FMF is truly under control?
Doctors cannot rely on how you feel to know if your FMF is fully controlled. They monitor specific inflammatory markers in your blood, such as SAA (Serum Amyloid A) and CRP (C-Reactive Protein), to detect silent inflammation between attacks.
What should I do if colchicine upsets my stomach?
If you are experiencing stomach upset or other gastrointestinal side effects, contact your doctor right away instead of stopping your medication. They can often manage these issues by adjusting your dose, splitting it throughout the day, or exploring alternative medications.
Is it ever safe for an FMF patient to stop taking colchicine?
A very small percentage of adults (about 3%) with mild disease and no high-risk genetic mutations might achieve remission without colchicine. However, this is extremely rare and requires intense, ongoing monitoring by a specialist to prevent hidden organ damage.

Questions for Your Doctor

4 questions

  • •Can we check my SAA and CRP levels to ensure I don't have subclinical inflammation even though I feel fine?
  • •Do I have a high-risk MEFV genetic mutation, such as M694V, and how does that affect my long-term treatment plan?
  • •If I am experiencing stomach upset or other side effects, what are my options for adjusting my dose or trying alternative treatments rather than stopping completely?
  • •What is our specific target goal for my inflammatory markers during these attack-free periods?

Questions for You

3 questions

  • •Am I considering stopping colchicine because I truly believe I am cured, or am I actually just frustrated by daily medication side effects?
  • •Have I ever had my specific genetic profile (MEFV mutation type) tested and discussed with my rheumatologist?
  • •How consistently have I been taking my daily colchicine over the past year, and have I missed doses without telling my doctor?

Related questions

Can You Eat Grapefruit While Taking Colchicine for FMF?What Triggers Familial Mediterranean Fever Attacks?FMF Attack vs Appendicitis: How to Tell the DifferenceCan You Have FMF If Your Genetic Test Is Negative?How Did I Get FMF? Inheritance & Carriers ExplainedHow to Manage Colchicine Stomach Upset & DiarrheaHow do you treat an active FMF attack?Why Do IL-1 Inhibitors Work When Colchicine Fails?Is Colchicine Safe During Pregnancy for FMF?Is Familial Mediterranean Fever an Autoimmune Disease?Does the M694V Mutation Make FMF Symptoms More Severe?What is Protracted Febrile Myalgia Syndrome (PFMS)?Why Is the SAA Blood Test Important for FMF Patients?What Are the Signs of AA Amyloidosis in FMF?

References

References (19)
  1. 1

    Familial Mediterranean fever: overview of pathogenesis, clinical features and management.

    Migita K, Asano T, Sato S, et al.

    Immunological medicine 2018; (41(2)):55-61 doi:10.1080/13497413.2018.1481579.

    PMID: 30938266
  2. 2

    Familial Mediterranean fever in childhood: a single-center experience.

    Barut K, Sahin S, Adrovic A, et al.

    Rheumatology international 2018; (38(1)):67-74 doi:10.1007/s00296-017-3796-0.

    PMID: 28828621
  3. 3

    Cardiac disease in familial Mediterranean fever.

    Erken E, Erken E

    Rheumatology international 2018; (38(1)):51-58 doi:10.1007/s00296-017-3853-8.

    PMID: 29051974
  4. 4

    Serum Amyloid A Level in Egyptian Children with Familial Mediterranean Fever.

    Lofty HM, Marzouk H, Farag Y, et al.

    International journal of rheumatology 2016; (2016()):7354018 doi:10.1155/2016/7354018.

    PMID: 28070191
  5. 5

    Evaluation of cardiac functions in children with familial Mediterranean fever.

    Yildirim Arslan S, Gurses D, Yuksel S

    Cardiology in the young 2024; (34(8)):1754-1763 doi:10.1017/S1047951124000787.

    PMID: 38584318
  6. 6

    Shear wave elastography evaluation of liver, pancreas, spleen and kidneys in patients with familial mediterranean fever and amyloidosis.

    Bayramoglu Z, Akyol Sari ZN, Koker O, et al.

    The British journal of radiology 2021; (94(1128)):20210237 doi:10.1259/bjr.20210237.

    PMID: 34520686
  7. 7

    Characteristics and course of patients with AA amyloidosis: single centre experience with 174 patients from Turkey.

    Bektas M, Koca N, Oguz E, et al.

    Rheumatology (Oxford, England) 2024; (63(2)):319-328 doi:10.1093/rheumatology/kead465.

    PMID: 37738242
  8. 8

    Changing epidemiology of AA amyloidosis: clinical observations over 25 years at a single national referral centre.

    Lane T, Pinney JH, Gilbertson JA, et al.

    Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis 2017; (24(3)):162-166 doi:10.1080/13506129.2017.1342235.

    PMID: 28686088
  9. 9

    Colchicine, Biologic Agents and More for the Treatment of Familial Mediterranean Fever. The Old, the New, and the Rare.

    Portincasa P

    Current medicinal chemistry 2016; (23(1)):60-86 doi:10.2174/0929867323666151117121706.

    PMID: 26572612
  10. 10

    Colchicine-Treated Familial Mediterranean Fever Patients Are Associated With a Lower Prevalence of Mitral Annular Calcification.

    Cüre O, Durak H, Çetin M, et al.

    Echocardiography (Mount Kisco, N.Y.) 2026; (43(3)):e70415 doi:10.1111/echo.70415.

    PMID: 41758070
  11. 11

    Arterial stiffness in Familial Mediterranean Fever: correlations with disease-related parameters and colchicine treatment.

    Sgouropoulou V, Stabouli S, Trachana M

    Clinical rheumatology 2019; (38(9)):2577-2584 doi:10.1007/s10067-019-04601-6.

    PMID: 31127463
  12. 12

    The Value of Serum Amyloid A Levels in Familial Mediterranean Fever to Identify Occult Inflammation During Asymptomatic Periods.

    Çakan M, Karadağ ŞG, Tanatar A, et al.

    Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 2021; (27(1)):1-4 doi:10.1097/RHU.0000000000001134.

    PMID: 31524848
  13. 13

    Evaluation of the Inflammatory Response After Eradication of Helicobacter pylori in Patients With Familial Mediterranean Fever.

    Altunok M, Albayrak F

    Journal of clinical gastroenterology 2024; (58(3)):253-258 doi:10.1097/MCG.0000000000001861.

    PMID: 37436837
  14. 14

    French protocol for the diagnosis and management of familial Mediterranean fever.

    Georgin-Lavialle S, Savey L, Cuisset L, et al.

    La Revue de medecine interne 2023; (44(11)):602-616 doi:10.1016/j.revmed.2023.10.441.

    PMID: 37903671
  15. 15

    Colchicine treatment can be discontinued in a selected group of pediatric FMF patients.

    Cohen K, Spielman S, Semo-Oz R, et al.

    Pediatric rheumatology online journal 2023; (21(1)):2 doi:10.1186/s12969-022-00780-w.

    PMID: 36600239
  16. 16

    Colchicine discontinuation in familial Mediterranean fever: short-term outcomes by pre-discontinuation attack frequency.

    Aktas B, Parlar K, Senturk B, et al.

    Clinical rheumatology 2026; (45(2)):1257-1265 doi:10.1007/s10067-025-07874-2.

    PMID: 41518583
  17. 17

    Discontinuing colchicine in symptomatic carriers for MEFV (Mediterranean FeVer) variants.

    Sönmez HE, Batu ED, Bilginer Y, Özen S

    Clinical rheumatology 2017; (36(2)):421-425 doi:10.1007/s10067-016-3421-8.

    PMID: 27679472
  18. 18

    Relationship between clinical findings and genetic mutations in patients with familial Mediterranean fever.

    Kilic A, Varkal MA, Durmus MS, et al.

    Pediatric rheumatology online journal 2015; (13()):59 doi:10.1186/s12969-015-0057-1.

    PMID: 26759267
  19. 19

    Familial Mediterranean Fever-Related Amyloidosis in Turkey: A Need for a Familial Mediterranean Fever Registry.

    Helvaci O, Yasar E

    Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation 2023; (21(Suppl 2)):101-104 doi:10.6002/ect.IAHNCongress.24.

    PMID: 37496356

This page provides general educational information about colchicine therapy for FMF. Never stop or adjust your medication without first consulting your prescribing rheumatologist, as doing so can risk permanent organ damage.

Get notified when new evidence is published on Familial Mediterranean fever.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.